194 related articles for article (PubMed ID: 22294052)
41. Co-occurrence of neurofibromatosis type 1 and optic nerve gliomas with autosomal dominant polycystic kidney disease type 2.
Peces R; Mena R; Martín Y; Hernández C; Peces C; Tellería D; Cuesta E; Selgas R; Lapunzina P; Nevado J
Mol Genet Genomic Med; 2020 Aug; 8(8):e1321. PubMed ID: 32533764
[TBL] [Abstract][Full Text] [Related]
42. Neurofibromatosis type 1 and childhood cancer.
Matsui I; Tanimura M; Kobayashi N; Sawada T; Nagahara N; Akatsuka J
Cancer; 1993 Nov; 72(9):2746-54. PubMed ID: 8402499
[TBL] [Abstract][Full Text] [Related]
43. Synchronous Upper Intestinal Neurofibromas and Duodenal Periampullary Well-Differentiated Neuroendocrine Tumor Associated With Neurofibromatosis 1.
Balmer JC; Mikhaylov Y; Lewin DN; Mahvi DM; Ramsay Camp E
Am Surg; 2021 Jan; 87(1):128-130. PubMed ID: 32856931
[TBL] [Abstract][Full Text] [Related]
44. Malignant fibrous histiocytoma of the larynx in a patient with neurofibromatosis type 1.
Pata YS; Unal M; Polat A
B-ENT; 2008; 4(2):117-20. PubMed ID: 18681209
[TBL] [Abstract][Full Text] [Related]
45. Dissecting Clinical Heterogeneity in Neurofibromatosis Type 1.
Monroe CL; Dahiya S; Gutmann DH
Annu Rev Pathol; 2017 Jan; 12():53-74. PubMed ID: 28135565
[TBL] [Abstract][Full Text] [Related]
46. Neurofibromatosis type 1, gastrointestinal stromal tumor, leiomyosarcoma and osteosarcoma: four cases of rare tumors and a review of the literature.
Afşar CU; Kara IO; Kozat BK; Demiryürek H; Duman BB; Doran F
Crit Rev Oncol Hematol; 2013 May; 86(2):191-9. PubMed ID: 23218951
[TBL] [Abstract][Full Text] [Related]
47. Pulmonary hypertension associated with neurofibromatosis type 1.
Jutant EM; Girerd B; Jaïs X; Savale L; O'Connell C; Perros F; Sitbon O; Humbert M; Montani D
Eur Respir Rev; 2018 Sep; 27(149):. PubMed ID: 30158278
[TBL] [Abstract][Full Text] [Related]
48. [Neurofibromatosis type 1 --Recklinghausen's disease; pathogenesis and clinical symptoms].
Stenzel A; Kostuch M; Wojcierowski J
Med Wieku Rozwoj; 1999; 3(1):41-6. PubMed ID: 10910637
[TBL] [Abstract][Full Text] [Related]
49. Cancer and Central Nervous System Tumor Surveillance in Pediatric Neurofibromatosis 1.
Evans DGR; Salvador H; Chang VY; Erez A; Voss SD; Schneider KW; Scott HS; Plon SE; Tabori U
Clin Cancer Res; 2017 Jun; 23(12):e46-e53. PubMed ID: 28620004
[TBL] [Abstract][Full Text] [Related]
50. Clinical and molecular characterization of 112 single-center patients with Neurofibromatosis type 1.
Corsello G; Antona V; Serra G; Zara F; Giambrone C; Lagalla L; Piccione M; Piro E
Ital J Pediatr; 2018 Apr; 44(1):45. PubMed ID: 29618358
[TBL] [Abstract][Full Text] [Related]
51. Aberrant Myeloid Differentiation Contributes to the Development of Osteoporosis in Neurofibromatosis Type 1.
Rhodes SD; Yang FC
Curr Osteoporos Rep; 2016 Feb; 14(1):10-5. PubMed ID: 26932441
[TBL] [Abstract][Full Text] [Related]
52. Endocrine implications of neurofibromatosis 1 in childhood.
Bizzarri C; Bottaro G
Horm Res Paediatr; 2015; 83(4):232-41. PubMed ID: 25659607
[TBL] [Abstract][Full Text] [Related]
53. Association Between Juvenile Myelomonocytic Leukemia, Juvenile Xanthogranulomas and Neurofibromatosis Type 1: Case Report and Review of the Literature.
Paulus S; Koronowska S; Fölster-Holst R
Pediatr Dermatol; 2017 Mar; 34(2):114-118. PubMed ID: 28111791
[TBL] [Abstract][Full Text] [Related]
54. [Type 1 neurofibromatosis: Onset of two tumors before the age of 5years].
Remillieux M; Durand C; Sartelet H; Piolat C; Bourgeois E; Pommier P; Hameury F; Dieterich K; Vidaud D; Perret C
Arch Pediatr; 2017 Oct; 24(10):986-990. PubMed ID: 28870819
[TBL] [Abstract][Full Text] [Related]
55. A case of neurofibromatosis and multiple sclerosis.
Spinicci G; Cherchi MV; Murru R; Conti M; Marrosu MG
Neurol Sci; 2010 Oct; 31(5):631-4. PubMed ID: 20424878
[TBL] [Abstract][Full Text] [Related]
56. Comparative study of the ophthalmological examinations in neurofibromatosis type 1. Proposal for a new screening algorithm.
Caen S; Cassiman C; Legius E; Casteels I
Eur J Paediatr Neurol; 2015 Jul; 19(4):415-22. PubMed ID: 25797697
[TBL] [Abstract][Full Text] [Related]
57. Lung parenchima changes in neurofibromatosis type 1.
Ilić A; Raljević S; Adzić T; Vesna Skodrić-Trifunović ; Stanimirović J
Vojnosanit Pregl; 2016 Feb; 73(2):202-4. PubMed ID: 27071290
[TBL] [Abstract][Full Text] [Related]
58. CNS Tumors in Neurofibromatosis.
Campian J; Gutmann DH
J Clin Oncol; 2017 Jul; 35(21):2378-2385. PubMed ID: 28640700
[TBL] [Abstract][Full Text] [Related]
59. Gastrointestinal juvenile-like (inflammatory/hyperplastic) mucosal polyps in neurofibromatosis type 1 with no concurrent genetic or clinical evidence of other syndromes.
Ravegnini G; Quero G; Sammarini G; Giustiniani MC; Castri F; Pomponi MG; Angelini S; Alfieri S; Genuardi M; Zamboni G; Ricci R
Virchows Arch; 2019 Feb; 474(2):259-264. PubMed ID: 30276464
[TBL] [Abstract][Full Text] [Related]
60. Ophthalmic manifestations in neurofibromatosis type 1.
Kinori M; Hodgson N; Zeid JL
Surv Ophthalmol; 2018; 63(4):518-533. PubMed ID: 29080631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
